[6] Hanlon et al.[7]

in the UK have made a case for a ‘fifth wave’ C59 wnt mw in public health concerned with the problems of obesity, social inequalities, and loss of well-being. The first wave of public health responses improved public health after the industrial revolution; the second wave impacted public health based upon the scientific method and subsequent discoveries; the third wave emanated from the implementation of the UK National Health Service and the fourth wave was influenced by medical care interventions affecting mortality.[7] Hanlon et al.[7] view obesity as something that can be treated by impacting the secondary clinical consequences of obesity, a task that they view as very expensive and not dealing with an underlying problem. Hanlon et al.[7] view the impact upon the unhealthy, societal acceptance of obesity as ‘normal’ as the key focal point for change. Changing the view of obesity will entail a complete shift in how societies view the issue of obesity to one examining root causes that have commercial and social impacts.[7] George et al.[8] suggest that there are opportunities to extend weight management find more services from community pharmacies, but findings from a study they conducted in 2010 indicate that expectations on the part of the public will need to be altered for acceptance. Pharmacists can play a

much more active role in dealing with the public health problem of obesity and overweight. There remains a need to produce evidence Tau-protein kinase from pharmacy practice research for the benefit of pharmacists’ involvement in directed obesity and overweight patient counselling, pharmacist-directed weight management protocols and the impact of these research endeavours on patient outcomes. Research can inform practice and provide for a much more proactive involvement for pharmacists’ interventions. Pharmacists can serve as a public health resource providing information and referrals for help for patients. Pharmacists can, at every

visit, calculate BMIs and counsel patients with elevated BMIs regarding the continuing and potentials risks associated with high BMIs and the negative influence elevated BMIs has upon the therapeutic options provided by medications to treat chronic conditions.[9] Pharmacists can collaborate with other health professionals within a medical home[10] and/or primary care practice to share information with other providers and the patients on means to help patients take advantage of self-help options available. Within professional societies and organizations, pharmacists can collaborate locally, regionally, nationally and internationally to focus other professional and the pharmacy profession’s attention towards the problem of obesity and overweight and keep this dramatic public health concern in the spotlight.